Compare RAMP & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAMP | HTFL |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 1994 | 2025 |
| Metric | RAMP | HTFL |
|---|---|---|
| Price | $37.76 | $49.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $35.60 | ★ $38.20 |
| AVG Volume (30 Days) | 901.0K | ★ 2.1M |
| Earning Date | 05-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22500.00 | 82.37 |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $812,940,000.00 | $176,034,000.00 |
| Revenue This Year | $11.18 | $27.66 |
| Revenue Next Year | $9.09 | $23.55 |
| P/E Ratio | $134.84 | ★ N/A |
| Revenue Growth | 9.03 | ★ 39.92 |
| 52 Week Low | $21.71 | $20.13 |
| 52 Week High | $38.23 | $51.78 |
| Indicator | RAMP | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 75.37 |
| Support Level | $37.65 | $24.30 |
| Resistance Level | $37.92 | $51.19 |
| Average True Range (ATR) | 0.14 | 2.53 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 77.89 | 77.58 |
LiveRamp Holdings Inc is a technology company that empowers marketers and media owners to deliver and measure marketing performance everywhere it matters. Its data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks, unlocking insights that deliver transformational consumer experiences and drive measurable business outcomes. The group's platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by customers and partners and the networked platform. It generates the geographic revenue from the United States, followed by Europe, Asia-Pacific ("APAC"), and Other.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.